MicroTech Medical (Hangzhou) Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
MicroTech Medical (Hangzhou) has a total shareholder equity of CN¥2.0B and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.2B and CN¥155.4M respectively.
Belangrijke informatie
1.0%
Verhouding schuld/eigen vermogen
CN¥20.01m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥1.81b |
| Aandelen | CN¥2.01b |
| Totaal verplichtingen | CN¥155.39m |
| Totaal activa | CN¥2.17b |
Recente financiële gezondheidsupdates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Analyse van de financiële positie
Kortlopende schulden: 2235's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥150.8M).
Langlopende schulden: 2235's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥4.6M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 2235 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if 2235's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 2235 has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: 2235 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36.9% each year